Sunday, November 19, 2017 12:53:16 AM
My point is if the current Management team will have the same perseverance, creativity and Patience in this product, they have a chance to be at the same level of ISRG now. Titan has an outstanding surgeon advisory board, they can never get wrong with these surgeons, this is already a huge advantage in their arsenal. All they need right now is the capitalization money to get their product out their FDA cleared and commercialized. Knowing how OR's work, those surgeons that invested 3.4m out of their money will surely influence their respective colleagues and Hospital to push the product that they want to use for their surgeries after all, Surgeons are still the one's that bring patients that results to Hospital profits. And I tell you this, the OR brings in the highest percentage reimbursement money for the hospital, the reason why Hospital Admins cater to every surgeons demand especially if they have most block day. Surgeons know this that's why most of them are nasty arrogant entitled pricks
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM